- Phosphodiesterase inhibitors - a new promise in the tratment of COPD?2010 | Second Faculty of Medicine
- Avanafil, a new inhibitor of phosphodiesterase type 5 for the treatment of erectile dysfunction2014 | First Faculty of Medicine
- Phosphodiesterase type 5 inhibitors use and risk of colorectal cancer: a systematic review and meta-analysis2021 | Faculty of Pharmacy in Hradec Králové
- Catalytic enhancement of the heme-based oxygen-sensing phosphodiesterase EcDOS by hydrogen sulfide is caused by changes in heme coordination structure2015 | Faculty of Science
- Phosphodiesterase inhibitors in the therapy of severe septic shock2001 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Phosphodiesterase in the heart of two inbred rat strains: effect of restraint stress and amphetaminePublication without faculty affiliation
- Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice2006 | First Faculty of Medicine
- Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice2006 | Faculty of Physical Education and Sport
- Insulin resistance in phosphodiesterase 3B knockout micePublication without faculty affiliation
- Endothelial cyclic AMP-phosphodiesterase activity in Lewis and Sprague-Dawley rats after restraint stress or amphetamine treatmentPublication without faculty affiliation
- In situ detection of cyclic AMP-phosphodiesterase activity in the heart of Lewis and Sprague-Dawley rats: the effect of restraint stress or amphetamine application2004 | First Faculty of Medicine
- In situ detection of cyclic AMP-phosphodiesterase activity in the heart of Lewis and Sprague-Dawley rats: the effect of restraint stress or amphetamine application2004 | Faculty of Physical Education and Sport
- Avanafil - a novel phosphodiesterase inhibitor for treating erestile dyscunction in clinical practice. How is it different from the established molecules? +12015 | Third Faculty of Medicine
- Indications and effectiveness of anti-inflammatory therapy in COPD roflumilast2013 | Second Faculty of Medicine
- New treatment options for chronic inflammation associated with COPD2011 | Second Faculty of Medicine
- Erectile dysfunction therapy according to the European Association of Urology Guidelines2014 | First Faculty of Medicine
- Pulmonary arterial hypertension2009 | First Faculty of Medicine
- New method of administration of alprostadil in the treatment of erectile dysfunction2018 | First Faculty of Medicine
- Treatment of erectile dysfunction and priapism2015 | First Faculty of Medicine
- Conversion of a heme-based oxygen sensor to a heme oxygenase by hydrogen sulfide: effects of mutations in the heme distal side of a heme-based oxygen sensor phosphodiesterase (Ec DOS)2013 | Faculty of Science
- Do you consider the diagnosis of pulmonary arterial hypertension in elderly patients?2009 | First Faculty of Medicine
- Do you consider the diagnosis of pulmonary arterial hypertension in elderly patients?2009 | Publication without faculty affiliation
- SMPD1 variants do not have a major role in rapid eye movement sleep behavior disorder2020 | First Faculty of Medicine
- An algorithm of conservative erectile dysfunction treatment2023 | First Faculty of Medicine
- Phosphodiesterase-5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide-mediated lipolysis2007 | Third Faculty of Medicine
- Takotsubo cardiomyopathy in a patient with essential thrombocythemia treated with anagrelide: Case report2018 | First Faculty of Medicine
- Apremilast -small molecule with the substantial therapeutical impact on the inflammation in patients with immunopathological disorders2019 | Faculty of Medicine in Hradec Králové
- Basic treatment options for erectile dysfunction in cancer patients in practice2023 | First Faculty of Medicine
- Erectile dysfunction and diabetes mellitus2015 | First Faculty of Medicine
